Evidence map›Paper›PMID 20421952›Full record

ArticlePsycho-social medicine2010

Excess direct medical costs of severe obesity by socioeconomic status in German adults.

Thomas von Lengerke, Jürgen John, Andreas Mielck, KORA Study Group

Abstract read
In one paragraph

Article in Psycho-social medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The costs and consequences of obesity in Germany: a new approach from a prevalence and life-cycle perspective.The European journal of health economics : HEPAC : health economics in prevention and care · 2016
    Article
  5. Article
  6. The economic impact of chronic pain: a nationwide population-based cost-of-illness study in Portugal.The European journal of health economics : HEPAC : health economics in prevention and care · 2016
    Article
  7. The influence of obesity and overweight on medical costs: a panel data perspective.The European journal of health economics : HEPAC : health economics in prevention and care · 2015
    Article
  8. Article
  9. Article
  10. Associations of socioeconomic status with migraine and non-migraine headache.Cephalalgia : an international journal of headache · 2012
    Article
  11. Scalable office-based health care.Health services management research · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thomas von LengerkeHannover Medical School, Medical Psychology Unit, Hannover, Germany Helmholtz Center Munich - German Research Center for Environmental Health, Institute of Health Economics and Health Care Management, Neuherberg, Germany.
Jürgen John
Andreas Mielck
KORA Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveExcess direct medical costs of severe obesity are by far higher than of moderate obesity. At the same time, severely obese adults with low socioeconomic status (SES) may be expected to have higher excess costs than those with higher SES, e.g. due to more comorbidities. This study compares excess costs of severe obesity among German adults across different SES groups.

methodsIn a subsample (N=947) of the KORA-Survey S4 1999/2001 (a cross-sectional health survey in the Augsburg region, Germany; age group: 25-74 years), visits to physicians, inpatient days in hospital, and received and purchased medication were assessed via computer-assisted telephone interviews (CATI) over half a year. Body mass index (BMI in kg/m(2)) was measured anthropometrically. SES was determined via reports of education, income, and occupational status from computer-assisted personal interviews (CAPI) (used both as single indicators, and as indexed by the Helmert algorithm); due to small subsample sizes all were median-split. Data of respondents in normal weight (18.5 </= BMI < 25), preobese (25 </= BMI < 30), moderately (class 1:30 </= BMI < 35) and severely obese (classes 2-3: BMI >/= 35) range were analysed by generalized linear models with mixed poisson-gamma (Tweedie) distributions. Physician visits and inpatient days were valuated as recommended by the Working Group METHODS in Health Economic Evaluation (AG MEG), and drugs were valuated by actual costs. Sex, age, kind of sickness fund (statutory/private) and place of residence (urban/rural) were adjusted for, and comorbidities were considered by the Physical Functional Comorbidity Index (PFCI).

resultsExcess costs of severe obesity were higher in respondents with high SES, regardless of the SES indicator used. For instance, annual excess costs were almost three times higher in those with an above-median SES-Index as compared with those with a median or lower SES-Index (plus euro 2,966 vs. plus euro 1,012; contrast significant at p<.001). Mediation of excess costs of severe obesity by physical comorbidities pertained to the low SES-Index and the low occupational status groups: differences in costs between severe obesity and normal weight were still positive, but statistically insignificant, in the lower status groups after adjusting for the PFCI, but still positive and significant given higher SES. For example, severe obesity's excess costs were euro 2,406 after PFCI-adjustment in the high SES-Index group (p<.001), but euro 539 in the lower status group (p=.17). At the same time, physical comorbidities as defined by the PCFI increased with BMI and decreased with SES, however the factors BMI and SES did not significantly interact in this context.

conclusionsTo our knowledge, this is the first study to show in Germany that excess direct medical costs of severe obesity are not distributed equitably across different SES groups, do not reflect comorbidity status, and are significantly higher in those with high SES than in those with lower SES. Thus, allocation of health care resources spent on severely obese adults seems to be in need of readjustment towards an equitable utilization across all socioeconomic groups.

Indexed as

comorbiditiesGermanyhealth care costsobesitysocioeconomic status

Identifiers

PMID20421952
PMCPMC2858876

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.